found that microRNA-4429 (miR-4429) can inhibit m6A modification by targeting METTL3, leading to the stabilization of SEC62 homolog, preprotein translocation factor (SEC62) to prevent the progression of gastric cancer (13). This evidence concerns the gene SEC62 and gastric cancer.